MacroGenics, Inc.MGNXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P62
Within normal range
vs 2Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.87% |
| Q3 2025 | -19.81% |
| Q2 2025 | 2.75% |
| Q1 2025 | 2.08% |
| Q4 2024 | -4.08% |
| Q3 2024 | -21.63% |
| Q2 2024 | 12.39% |
| Q1 2024 | -2.79% |
| Q4 2023 | 57.15% |
| Q3 2023 | -30.30% |
| Q2 2023 | -5.76% |
| Q1 2023 | 0.48% |
| Q4 2022 | -5.26% |
| Q3 2022 | -6.87% |
| Q2 2022 | -15.78% |
| Q1 2022 | 10.00% |
| Q4 2021 | 12.10% |
| Q3 2021 | -10.68% |
| Q2 2021 | 5.01% |
| Q1 2021 | 25.58% |
| Q4 2020 | -5.28% |
| Q3 2020 | -22.14% |
| Q2 2020 | 17.30% |
| Q1 2020 | -11.99% |
| Q4 2019 | 23.87% |
| Q3 2019 | -12.81% |
| Q2 2019 | 9.31% |
| Q1 2019 | 0.29% |
| Q4 2018 | 1.53% |
| Q3 2018 | -11.14% |
| Q2 2018 | 13.89% |
| Q1 2018 | 17.14% |
| Q4 2017 | -4.88% |
| Q3 2017 | 18.93% |
| Q2 2017 | 5.06% |
| Q1 2017 | 5.44% |
| Q4 2016 | 2.68% |
| Q3 2016 | -9.13% |
| Q2 2016 | 21.92% |
| Q1 2016 | -8.98% |